1. Cumulative Radiation Dose in Patients With Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations 
Kate Hanneman, MD, Marie E. Faughnan, MD, MSc, Vikramaditya Prabhudesai, MBBS, MS, FRCR 
Canadian Association of Radiologists Journal 
Volume 65, Issue 2, Pages (May 2014)
DOI: /j.carj
Copyright © 2014 Canadian Association of Radiologists Terms and Conditions

2. Figure 1
A 30-year-old woman with hereditary hemorrhagic telangiectasia. (A) Frontal chest radiograph and (B) coronal computed tomography image, demonstrating a right upper lobe pulmonary arteriovenous malformations (arrows).
Canadian Association of Radiologists Journal  , DOI: ( /j.carj )
Copyright © 2014 Canadian Association of Radiologists Terms and Conditions

3. Figure 2
Distribution of individual cumulative effective dose (CED) estimates for total study cohort (n = 246). CED exceeded 50 mSv and 100 mSv in 84 (34%) and 26 (11%) patients, respectively. This figure is available in colour online at
Canadian Association of Radiologists Journal  , DOI: ( /j.carj )
Copyright © 2014 Canadian Association of Radiologists Terms and Conditions

4. Figure 3
(A) Percentage contribution of each imaging modality to the number of procedures performed for the study cohort. (B) Percentage contribution of each imaging modality to the total study cohort cumulative effective dose. CT = computed tomography; MRI = magnetic resonance imaging. This figure is available in colour online at
Canadian Association of Radiologists Journal  , DOI: ( /j.carj )
Copyright © 2014 Canadian Association of Radiologists Terms and Conditions